Pathophysiology of pediatric movement disorders

Journal of Child Neurology

Volumn 18, Issue SUPPL. 1, 2003, Pages

  Sanger, Terence D ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ATAXIA; BRADYKINESIA; CHILD; CHOREA; CLINICAL FEATURE; DYSTONIA; HUMAN; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; MUSCLE RIGIDITY; MYOCLONUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SPASTICITY; SYMPTOM; TIC; TREMOR;

EID: 0042383448     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073803018001s0401     Document Type: Review

References (227)

1. Sanger T, Delgado M, Gaebler-Spira D, et al: Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003;111:e89-e97.
2. Crothers B, Paine R: The Natural History of Cerebral Palsy. Vol 2, Classics in Developmental Medicine, Mitchell R (ed). Philadelphia, JB Lippincott, 1959.
3. Wagley PF: A study of spasticity and paralysis. Bull Johns Hopkins Hosp 1945;77:218-273.
4. Myklebust BM, Gottlieb GL, Penn RD, Agarwal GC: Reciprocal excitation of antagonistic muscles as a differentiating feature in spasticity. Ann Neurol 1982;12:367-374.
5. Leonard CT, Hirschfield H, Moritoni T, Forssberg H: Myotatic reflex development in normal children and children with cerebral palsy. Exp Neurol 1991;111:379-382.
6. Lance JW: Pathophysiology of spasticity and clinical experience with baclofen, in Feldman RG, Young RR, Koella WP (eds): Spasticity: Disordered Motor Control. Chicago, Year Book Medical Publishers, 1980, 185-220.
7. O'Dwyer NJ, Ada L, Neilson PD: Spasticity and muscle contracture following stroke. Brain 1996:119(Pt 5):1737-1749.
8. Sinkjaer T, Toft E, Larsen K, et al: Non-reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity. Muscle Nerve 1993;16:69-76.
9. Dietz V, Trippel M, Berger W. Reflex activity and muscle tone during elbow movements in patients with spastic paresis. Ann Neurol 1991;30:767-779.
10. Burke D: Spasticity as an adaptation to pyramidal tract injury. Adv Neurol 1988;47:401-423.
11. Dietz V: Supraspinal pathways and the development of muscle-tone dysregulation. Dev Med Child Neurol 1999;41:708-715.
12. Hiersemenzel LP, Curt A, Dietz V: From spinal shock to spasticity: Neuronal adaptations to a spinal cord injury. Neurology 2000;54:1574-1582.
13. Katz RT, Rymer WZ: Spastic hypertonia: Mechanisms and measurement. Arch Phys Med Rehabil 1989;70:144-155.
14. Jobin A, Levin MF: Regulation of stretch reflex threshold in elbow flexors in children with cerebral palsy: a new measure of spasticity. Dev Med Child Neurol 2000;42:531-540.
15. Levin MF, Feldman AG: The role of stretch reflex threshold regulation in normal and impaired motor control. Brain Res 1994;657:23-30.
16. Lin FM, Sabbahi M: Correlation of spasticity with hyperactive stretch reflexes and motor dysfunction in hemiplegia. Arch Phys Med Rehabil 1999;80:526-530.
17. Mayer NH: Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl 1997;6:S1-S13.
18. O'Dwyer NJ, Ada L: Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia. Curr Opin Neurol 1996;9:451-455.
19. Sheean G: The pathophysiology of spasticity. Eur J Neurol 2002:9(Suppl 1):3-9; discussion 53-61.
20. Brown P: Pathophysiology of spasticity. J Neurol Neurosurg Psychiatry 1994;57:773-777.
21. Dietz V: Human neuronal control of automatic functional movements: interaction between central programs and afferent input. Physiol Rev 1992;72:33-69.
22. Sheean GL: Botulinum treatment of spasticity: why is it so difficult to show a functional benefit? Curr Opin Neurol 2001; 14:771-776.
23. Hinderer SR, Dixon K: Physiologic and clinical monitoring of spastic hypertonia. Phys Med Rehabil Clin North Am 2001; 12:733-746.
24. Back SA, Han BH, Luo NL, et al: Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002;22: 455-463.
25. Dewald JP, Pope PS, Given JD, et al: Abnormal muscle coactivation patterns during isometric torque generation at the elbow and shoulder in hemiparetic subjects. Brain 1995;118(Pt 2):495-510.
26. Kuchler M, Fouad K, Weinmann O, et al: Red nucleus projections to distinct motor neuron pools in the rat spinal cord. J Comp Neurol 2002;448:349-359.
27. Yeomans JS, Li L, Scott BW, Frankland PW: Tactile, acoustic and vestibular systems sum to elicit the startle reflex. Neurosci Biobehav Rev 2002;26:1-11.
28. Heffner R, Masterton B: Variation in form of the pyramidal tract and its relationship to digital dexterity. Brain Behav Evol 1975;12:161-200.
29. Heffner RS, Masterton RB: The role of the corticospinal tract in the evolution of human digital dexterity. Brain Behav Evol 1983;23:165-183.
30. Chen XY, Feng-Chen KC, Chen L, et al: Short-term and medium-term effects of spinal cord tract transections on soleus H-reflex in freely moving rats. J Neurotrauma 2001;18:313-327.
31. Maier MA, Oliver E, Baker SN, et al: Direct and indirect corticospinal control of arm and hand motoneurons in the squirrel monkey (Saimiri sciureus). J Neurophysiol 1997;78:721-733.
32. Iwaniuk AN, Pellis SM, Whishaw IQ: Is digital dexterity really related to corticospinal projections?: A re-analysis of the Heffner and Masterton data set using modern comparative statistics. Behav Brain Res 1999;101:173-187.
33. Young RR: Spasticity: A review. Neurology 1994;44(11 Suppl 9):S12-S20.
34. Petersen MC, Palmer FB: Advances in prevention and treatment of cerebral palsy. Ment Retard Dev Disabil Res Rev 2001;7(1):30-37.
35. Hill AV: The mechanics of active muscle. Proc R Soc Lond B Biol Sci 1953;141:104-117.
36. Noth J, Schwarz M: Muscle tone: The neurophysiological basis and pathological changes. Klin Neurophysiol 1999;30:69-80.
37. Tardieu C, Lacert P, Lombard M, et al: H reflex and recovery cycle in spastic and normal children: intra- and inter-individual and inter-groups comparisons. Arch Phys Med Rehabil 1977;58:561-567.
38. Hagberg B: Pre-, peri- and postnatal prevention of major neuropediatric handicaps. Neuropadiatrie 1975;6:331-338.
39. Kyllerman M, Bager B, Bensch J, et al: Dyskinetic cerebral palsy. I. Clinical categories, associated neurological abnormalities and incidences. Acta Paediatr Scand 1982;71:543-550.
40. Kyllerman M: Dyskinetic cerebral palsy. II. Pathogenetic risk factors and intra-uterine growth. Acta Paediatr Scand 1982; 71:551-558.
41. Kyllerman M: Reduced optimality in pre- and perinatal conditions in dyskinetic cerebral palsy-Distribution and comparison to controls. Neuropediatrics 1983;4:29-36.
42. Nordmark E, Hagglund G, Lagergren J: Cerebral palsy in southern Sweden II. Gross motor function and disabilities. Acta Paediatr 2001;90:1277-82.
43. Nordmark E, Hagglund G, Lagergren J: Cerebral palsy in southern Sweden I. Prevalence and clinical features. Acta Paediatr 2001;90:1271-1276.
44. Lehericy S, Vidailhet M, Dormont D, et al: Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study. Arch Neurol 1996;53:241-250.
45. Karsidag S, Ozer F, Sen A, Arpaci B: Lesion localization in developing poststroke hand dystonia. Eur Neurol 1998;40:99-104.
46. Lenz FA, Suarez JI, Metman LV, et al: Pallidal activity during dystonia: Somatosensory reorganisation and changes with severity. J Neurol Neurosurg Psychiatry 1998;65:767-770.
47. Hallett M: Physiology of dystonia. Adv Neurol 1998;78:11-18.
48. Hallett M: The neurophysiology of dystonia. Arch Neurol 1998; 55:601-603.
49. John B, Klemm E, Haverkamp F: Evidence for altered basal ganglia and cortical functions in transient idiopathic dystonia. J Child Neurol 2000;15:820-822.
50. Krageloh-Mann I, Helber A, Mader I, et al: Bilateral lesions of thalamus and basal ganglia: Origin and outcome. Dev Med Child Neurol 2002;44:477-484.
51. Bara-Jimenez W, Shelton P, Sanger TD, Hallett M: Sensory discrimination capabilities in patients with focal hand dystonia. Ann Neurol 2000;47:377-380.
52. Sanger TD, Pascual-Leone A, Tarsy D, Schlaug G: Nonlinear sensory cortex response to simultaneous tactile stimuli in writer's cramp. Mov Disord 2002;17:105-111.
53. Sanger TD, Tarsy D, Pascual-Leone A: Abnormalities of spatial and temporal sensory discrimination in writer's cramp. Mov Disord 2001;16:94-99.
54. Bara-Jimenez W, Shelton P, Hallett M: Spatial discrimination is abnormal in focal hand dystonia. Neurology 2000;55:1869-1873.
55. Bara-Jimenez W, Catalan MJ, Hallett M, Gerloff C: Abnormal somatosensory homunculus in dystonia of the hand. Ann Neurol 1998;44:828-831.
56. Hallett M: Is dystonia a sensory disorder? Ann Neurol 1995; 38:139-140.
57. Sanger TD, Merzenich MM: Computational model of the role of sensory disorganization in focal task-specific dystonia. J Neurophysiol 2000;84:2458-2464.
58. Lenz FA, Byl NN: Reorganization in the cutaneous core of the human thalamic principal somatic sensory nucleus (ventral caudal) in patients with dystonia. J Neurophysiol 1999;82:3204-3212.
59. Lenz FA, Jaeger CJ, Seike MS, et al: Thalamic single neuron activity in patients with dystonia: Dystonia-related activity and somatic sensory reorganization. J Neurophysiol 1999;82:2372-2392.
60. Pizoli CE, Jinnah HA, Billingsley ML, Hess EJ: Abnormal cerebellar signaling induces dystonia in mice. J Neurosci 2002;22:7825-7833.
61. Alarcon F, Tolosa E, Munoz E: Focal limb dystonia in a patient with a cerebellar mass. Arch Neurol 2001;58:1125-1127.
62. Mink JW: The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 1996;50:381-425.
63. Tijssen MA, Marsden JF, Brown P: Frequency analysis of EMG activity in patients with idiopathic torticollis. Brain 2000:123(Pt 4):677-686.
64. Berardelli A, Rothwell JC, Hallett M, et al: The pathophysiology of primary dystonia. Brain 1998;121(Pt 7):1195-1212.
65. Nobrega JN, Richter A, Tozman N, et al: Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster. Neuroscience 1996;71:927-937.
66. Burgunder J, Richter A, Loscher W: Expression of cholecystokinin, somatostatin, thyrotropin-releasing hormone, glutamic acid decarboxylase and tyrosine hydroxylase genes in the central nervous motor systems of the genetically dystonic hamster. Exp Brain Res 1999;129:114-120.
67. Peacock L, Lublin H, Gerlach J: The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment. Eur J Pharmacol 1990;186:49-59.
68. Segawa M, Hosaka F, Miyagawa F, et al: Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14:215-233.
69. Segawa M, Nishiyama N, Nomura Y: DOPA-responsive dystonic parkinsonism-pathophysiologic considerations. Adv Neurol, 1999;80:389-400.
70. Nishiyama N, Yukishita S, Hagiwara H, et al: Gene mutation in hereditary progressive dystonia with marked diurnal fluctuation (HPD), strictly defined dopa-responsive dystonia. Brain Dev 2000;22(Suppl 1):S102-S106.
71. Vonsattel JP, Myers RH, Stevens TJ, et al: Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577.
72. Vonsattel JP, DiFiglia M: Huntington disease. J Neuropathol Exp Neurol 1998;57:369-384.
73. Reiner A, Albin RL, Anderson KD, et al: Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 1988;85:5733-5737.
74. Casey DE: Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys. Psychopharmacology 1992; 107:18-22.
75. Gerlach J, Kistrup K, Korsgaard S: Effect of selective D1 and D2 dopamine receptor antagonists and agonists in Cebus monkeys: Implications for acute and tardive dyskinesias. A preliminary report. Psychopharmacol Ser 1987;3:236-242.
76. Kistrup K Gerlach J: Selective D1 and D2 receptor manipulation in Cebus monkeys: Relevance for dystonia and dyskinesia in humans. Pharmacol Toxicol 1987;61:157-161.
77. Albin RL, Young AB, Penney JB: The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
78. Alexander GE,Crutcher MD: Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
79. DeLong MR: Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
80. Fahn S: Systemic therapy of dystonia. Can J Neurol Sci 1987;14(3 Suppl):528-532.
81. Burke RE, Fahn S, Marsden CD: Torsion dystonia: A double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986;36:160-164.
82. Burke RE, Fahn S: Serum trihexyphenidyl levels in the treatment of torsion dystonia. Neurology 1985;35:1066-1069.
83. Fahn S: High dosage anticholinergic therapy in dystonia. Neurology 1983;33:1255-1261.
84. Burke RE, Fahn S: Double-blind evaluation of trihexyphenidyl in dystonia. Adv Neurol 1983;37:189-192.
85. Fahn S: High-dosage anticholinergic therapy in dystonia. Adv Neurol 1983;37:177-188.
86. de la Vega MT, Nunez A, Arias Montano JA: Muscarinic M-1 and M-3 receptors in rat striatum: A binding study. Arch Med Res 1997;28:493-497.
87. Hussain N, Flumerfelt BA, Rajakumar N: Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens. Neuroscience 2002;112:427-438.
88. Puri SK, Volicer L, Choma P: Effect of dopamine and acetylcholine-receptor agonists and antagonists on cyclic nucleotide levels in rat cerebellum and striatum. Pharmacologist 1976;18:131.
89. Galarraga E, Hernandez-Lopez S, Reyes A, et al: Cholinergic modulation of neostriatal output: A functional antagonism between different types of muscarinic receptors. J Neurosci 1999;19:3629-3638.
90. Coker SB: Delayed-onset dystonia. Neurology 1991;41:1704-1705.
91. Burke RE, Fahn S, Gold AP: Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry 1980;43:789-797.
92. Scott BL, Jankovic J: Delayed-onset progressive movement disorders after static brain lesions. Neurology 1996;46:68-74.
93. Kumar R, Dagher A, Hutchinson WD, et al: Globus pallidus deep brain stimulation for generalized dystonia: Clinical and PET investigation. Neurology 1999;53:871-874.
94. Volkmann J, Benecke R: Deep brain stimulation for dystonia: Patient selection and evaluation. Mov Disord 2002;17(Suppl 3): S112-S115.
95. Vercueil L, Krack P, Pollak P: Results of deep brain stimulation for dystonia: A critical reappraisal. Mov Disord 2002;17(Suppl 3):S89-S93.
96. Roubertie A, Echenne B, Cif L, et al: Treatment of early-onset dystonia: Update and a new perspective. Childs Nerv Syst 2000; 16:334-340.
97. Coubes P, Roubertie A, Vayssiere N, et al: Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet 2000;355:2220-2221.
98. Centonze D, Picconi B, Gubellini P, et al: Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 2001;13:1071-1077.
99. Calabresi P, Pisani A, Centonze D, Bernardi G: Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission. Nihon Shinkei Seishin Yakurigaku Zasshi 1997;17:101-104.
100. Calabresi P, Pisani A, Centonze D, Bernardi G: Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neurosci Biobehav Rev 1997;21:519-523.
101. Calabresi P, Saiardi A, Pisani A, et al: Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J Neurosci 1997;17:4536-4544.
102. Calabresi P, Pisani A, Mercuri NB, Bernardi G: Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels. Eur J Neurosci 1992;4:929-935.
103. Calabresi P, Maj R, Pisani A, et al: Long-term synaptic depression in the striatum: Physiological and pharmacological characterization. J Neurosci 1992;12:4224-4233.
104. Narabayashi H: The neural mechanisms and progressive nature of symptoms of Parkinson's disease-Based on clinical, neurophysiological and morphological studies. J Neural Transm Park Dis Dement Sect 1995;10:63-75.
105. Yokochi M: Familial juvenile parkinsonism. Eur Neurol 1997;38(Suppl 1):29-33.
106. Gibb WR: Functional neuropathology in Parkinson's disease. Eur Neurol 1997;38(Suppl 2):21-25.
107. Kingston D: Tetrabenazine for involuntary movement disorders. Med J Aust 1979;1:628-630.
108. Marsden CD, Marion MH, Quinn N: The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984;47:1166-1173.
109. Jankovic J, Orman J: Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988;38:391-394.
110. Giladi N, Melamed E: Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism. Mov Disord 1999;14:158-159.
111. Berardelli A, Rothwell JC, Thompson PD, Hallett M: Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001:124(Pt 11):2131-2146.
112. Hallett M, Khoshbin S: A physiological mechanism of bradykinesia. Brain 1980;103:301-314.
113. Hallett M, Shahani BT, Young RR: Analysis of stereotyped voluntary movements at the elbow in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1977;40:1129-1135.
114. Hallett M: Clinical neurophysiology of akinesia. Rev Neurol 1990;146:585-590.
115. Nagatsu T, Ichinose H: GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson's disease. J Neural Transm Suppl 1997;49:203-209.
116. Segawa M, Nomura Y, Kase M: Hereditary progressive dystonia with marked diurnal fluctuation: Clinicopathophysiological identification in reference to juvenile Parkinson's disease. Adv Neurol 1987;45:227-234.
117. Olanow CW, Brin MF, Obeso JA: The role of deep brain stimulation as a surgical treatment for Parkinson's disease. Neurology 2000;55(12 Suppl 6):S60-S66.
118. Lang AE: Surgery for levodopa-induced dyskinesias. Ann Neurol 2000;47(4 Suppl 1):S193-S199; discussion S199-S202.
119. Levesque MF, Taylor S, Rogers R, et al: Subthalamic stimulation in Parkinson's disease. Preliminary results. Stereotact Funct Neurosurg 1999;72:170-173.
120. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP: Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: Results of a randomized, blinded pilot study. Neurosurgery 1999;45:1375-1382; discussion 1382-1384.
121. Nutt JG, Rufener SL, Carter JH, et al: Interactions between deep brain stimulation and levodopa in Parkinson's disease. Neurology 2001;57:1835-1842.
122. Wu YR, Levy R, Ashby P, et al: Does stimulation of the GPi control dyskinesia by activating inhibitory axons? Mov Disord 2001;16:208-216.
123. Berardelli A, Noth J, Thompson PD, et al: Pathophysiology of chorea and bradykinesia in Huntington's disease. Mov Disord 1999;14:398-403.
124. Genet F, Arslanoglu S, Uran N, Saylan B: Sydenham's chorea: Clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev 2002;24:73-76.
125. Visvanathan K, Trifiletti RR, Altemus M, Zabriskie JB, et al: Autoimmune mechanisms in movement disorders. Semin Pediatr Neurol 2000;7:103-107.
126. Font J, Cervera R, Espinosa G, et al: Systemic lupus erythematosus (SLE) in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998;57:456-459.
127. Louis ED, Lynch T, Cargan AL, Fahn S: Generalized chorea in an infant with semilobar holoprosencephaly. Pediatr Neurol 1995;13:355-357.
128. Pranzatelli MR: Movement disorders in childhood. Pediatr Rev 1996;17:388-394.
129. Woods CG, Taylor AM: Ataxia telangiectasia in the British Isles: The clinical and laboratory features of 70 affected individuals. QJM 1992;82:169-179.
130. Singer HS: Current issues in Tourette syndrome. Mov Disord 2000;15:1051-1063.
131. Singer HS, Giuliano JD, Zimmerman AM, Walkup JT: Infection: A stimulus for tic disorders. Pediatr Neurol 2000;22:380-383.
132. Hoekstra PJ, Kallenberg CG, Korf J, Minderoa RB: Is Tourette's syndrome an autoimmune disease? Mol Psychiatry 2002;7:437-445.
133. Murphy ML, Pichichero ME: Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002;156:356-361.
134. Bottas A, Richter MA: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Pediatr Infect Dis J 2002;21:67-71.
135. Orvidas LJ, Slattery MJ: Pediatric autoimmune neuropsychiatric disorders and streptococcal infections: Role of otolaryngologist. Laryngoscope 2001;111:1515-1519.
136. Leonard HL, Swedo SE: Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int J Neuropsychopharmacol 2001;4:191-198.
137. Muller N, Kroll B, Schwarz MJ, et al: Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res 2001;101:187-193.
138. Rosenberg KP: Tourette's syndrome and 'PANDAS.' Neurology 1998;51:1516.
139. Swedo SE, Leonard HL, Mittleman BB, et al: Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997;154:110-112.
140. Kossoff EH, Singer HS: Tourette syndrome: Clinical characteristics and current management strategies. Paediatr Drugs 2001;3:355-363.
141. Singer HS: Neurobiology of Tourette syndrome. Neurol Clin 1997;15:357-79.
142. Lees AJ, Robertson M, Trimble MR, Murray NM: A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol Neurosurg Psychiatry 1984;47:1-8.
143. Dulac O, Plouin P, Shewmon A: Myoclonus and epilepsy in childhood: 1996 Royaumont meeting. Epilepsy Res 1998;30:91-106.
144. Schor NF: Nervous system dysfunction in children with paraneoplastic syndromes. J Child Neurol 1992;7:253-258.
145. Plioplys AV, Greaves A, Yoshida W: Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics 1989;20:93-102.
146. Lopez-Ibor B, Schwartz AD: Neuroblastoma. Pediatr Clin North Am 1985;32:755-778.
147. Musarella MA, Chan HS, DeBoer G, Gallie BL: Ocular involvement in neuroblastoma: Prognostic implications. Ophthalmology 1984;91:936-940.
148. Rapin I: Myoclonus in neuronal storage and Lafora diseases. Adv Neurol 1986;43:65-85.
149. Niedermeyer E, Fineyre F, Riley T, Bird B: Myoclonus and the electroencephalogram, a review. Clin Electroencephalogr 1979;10:75-95.
150. Wallace SJ: Myoclonus and epilepsy in childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res 1998;29:147-154.
151. Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T: Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): Disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 1980;47:117-133.
152. Garg RK: Subacute sclerosing panencephalitis. Postgrad Med J 2002;78:63-70.
153. Licht DJ, Lynch DR: Juvenile dentatorubral-pallidoluysian atrophy: New clinical features. Pediatr Neurol 2002;26:51-54.
154. Becher MW, Rubinsztein DC, Leggo J, et al: Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disord 1997;12:519-530.
155. Oguni H, Fukuyama Y, Tanaka T, et al: Myoclonic-astatic epilepsy of early childhood-Clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome. Brain Dev 2001;23:757-764.
156. Oguni, H, Hayashi K, Awaya Y, et al: Severe myoclonic epilepsy in infants-A review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev 2001;23:736-748.
157. Dulac O: Epileptic encephalopathy. Epilepsia 2001;42(Suppl 3):23-26.
158. Fejerman N: Myoclonus and epilepsies. Indian J Pediatr 1997; 64:583-602.
159. Minassian BA, Sainz J, Delgado-Escueta AV: Genetics of myoclonic and myoclonus epilepsies. Clin Neurosci 1995;3:223-235.
160. Buchhalter JR: Inherited epilepsies of childhood. J Child Neurol 1994;9(Suppl 1):S12-S19.
161. Panzica F, Rubboli G, Franceschetti S, et al: Cortical myoclonus in Janz syndrome. Clin Neurophysiol 2001;112:1803-1809.
162. Hallett M: Myoclonus: Relation to epilepsy. Epilepsia 1985;26(Suppl 1):S67-S77.
163. Livingston S: Diagnosis and treatment of childhood myoclonic seizures. Pediatrics 1974;53:542-548.
164. Cockerell OC, Rothwell J, Thompson PD, et al: Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK. Brain 1996;119(Pt 2):393-407.
165. Hallett M: Physiology of human posthypoxic myoclonus. Mov Disord 2000;15(Suppl 1):8-13.
166. Rizvi AH, Karetzky MS: Action myoclonus after cerebral anoxia. N J Med 1993;90:918-920.
167. Kuzniecky R, Berkovic S, Andermann F, et al: Focal cortical myoclonus and rolandic cortical dysplasia: Clarification by magnetic resonance imaging. Ann Neurol 1988;23:317-325.
168. Wallace SJ: Management issues in severe childhood epilepsies. Seizure 1995;4:215-220.
169. Shibasaki H: Electrophysiological studies of myoclonus. Muscle Nerve 2000;23:321-335.
170. Ikeda A, Kakigi R, Funai N, et al: Cortical tremor: A variant of cortical reflex myoclonus. Neurology 1990;40:1561-1565.
171. Shibasaki H, Yamashita Y, Tobimatsu S, Neshige R: Electroencephalographic correlates of myoclonus. Adv Neurol 1986;43: 357-372.
172. Shibasaki H, Neshige R, Hashiba Y: Cortical excitability after myoclonus: Jerk-locked somatosensory evoked potentials. Neurology 1985;35:36-41.
173. Hallett M, Chadwick D, Marsden CD: Cortical reflex myoclonus. Neurology 1979;29:1107-1125.
174. Goetz CG, Carvey PM, Pappert EJ, et al: The role of the serotonin system in animal models of myoclonus. Adv Neurol 2002;89:244-248.
175. Darko W, Guharoy R, Rose F, et al: Myoclonus secondary to the concurrent use of trazodone and fluoxetine. Vet Hum Toxicol 2001;43:214-215.
176. Pappert EJ, Goetz CG, Vu TQ et al: Animal model of posthypoxic myoclonus: Effects of serotonergic antagonists. Neurology 1999;52:16-21.
177. Pappert EJ, Goetz CG, Stebbins GT, et al: 5-Hydroxytryptophan-induced myoclonus in guinea pigs: Mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol 1998;347:51-56.
178. Gambardella A, Quattrone A: Treatment of palatal myoclonus with sumatriptan. Mov Disord 1998;13:195.
179. Jaw SP, Dang T, Truong DD: Chronic treatments with 5-HT1A agonists attenuate posthypoxic myoclonus in rats. Pharmacol Biochem Behav 1995;52:577-580.
180. Pranzatelli MR: The pharmacology of antimyoclonic drugs. Clin Neurosci 1995;3:246-252.
181. Pranzatelli MR: Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists. Arch Neurol 1994;51:605-617.
182. Franz DN: Tremor in childhood. Pediatr Ann 1993;22:60-64.
183. Pranzatelli MR, Mott SH, Pavlakis SG, et al: Clinical spectrum of secondary parkinsonism in childhood: A reversible disorder. Pediatr Neurol 1994;10:131-140.
184. Loudianos G, Gitlin JD: Wilson's disease. Semin Liver Dis 2000;20:353-364.
185. Macfarlane PI, Walters M, Stutchfield P, Smith CS: A prospective study of symptomatic hypoglycaemia in childhood diabetes. Diabet Med 1989;6:627-630.
186. Yancey CL, Doughty RA, Athreya BH: Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum 1981;24:1389-1395.
187. Louis ED, Dure LS, Pullman S: Essential tremor in childhood: A series of nineteen cases. Mov Disord 2001;16:921-923.
188. Paulson GW: Benign essential tremor in childhood: Symptoms, pathogenesis, treatment. Clin Pediatr (Phila) 1976;15:67-70.
189. Growdon JH, Shahani BT, Young RR: The effect of alcohol on essential tremor. Neurology 1975;25:259-262.
190. Koster B, Deuschl G, Lauk M, et al: Essential tremor and cerebellar dysfunction: Abnormal ballistic movements. J Neurol Neurosurg Psychiatry 2002;73:400-405.
191. Deuschl G, Bergman H: Pathophysiology of nonparkinsonian tremors. Mov Disord 2002;17(Suppl 3):S41-S48.
192. Milanov I: Motoneuron activity in patients with different types of tremor. Electromyogr Clin Neurophysiol 2001;41:479-484.
193. Deuschl G, Raethjen J, Lindemann M, Krack P: The pathophysiology of tremor. Muscle Nerve 2001;24:716-735.
194. Hallett M: Overview of human tremor physiology. Mov Disord 1998;13(Suppl 3):43-48.
195. Lozano AM: Vim thalamic stimulation for tremor. Arch Med Res 2000;31:266-269.
196. Blond S, Ceparros-Lefebre D, Parker F, et al: Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992;77:62-68.
197. Calzetti S, Baratti M, Gresty M, Findley L: Frequency/amplitude characteristics of postural tremor of the hands in a population of patients with bilateral essential tremor: Implications for the classification and mechanism of essential tremor. J Neurol Neurosurg Psychiatry 1987;50:561-567.
198. Lank M, Timmer J, Guschlbauer B, et al: Variability of frequency and phase between antagonistic muscle pairs in pathological human tremors. Muscle Nerve 2001;24:1365-1370.
199. Akbostanci MC, Ulkatan S, Yigit A, et al: Difference of disability between electrophysiologic subgroups of essential tremor. Can J Neurol Sci 2000;27:60-64.
200. Bastian AJ, Zackowski KM, Thach WT: Cerebellar ataxia: Torque deficiency or torque mismatch between joints? J Neurophysiol 2000;83:3019-3030.
201. Topka H, Konczak K, Schneider K, et al: Multijoint arm movements in cerebellar ataxia: Abnormal control of movement dynamics. Exp Brain Res 1998;119:493-503.
202. Bastian AJ, Martin TA, Keating JG, Thach WT: Cerebellar ataxia: Abnormal control of interaction torques across multiple joints. J Neurophysiol 1996;76:492-509.
203. Thach WT, Perry JG, Kane SA, Goodkin HP: Cerebellar nuclei: Rapid alternating movement, motor somatotopy, and a mechanism for the control of muscle synergy. Rev Neurol 1993; 149:607-628.
204. Thach WT, Goodkin HP, Keating JG: The cerebellum and the adaptive coordination of movement. Annu Rev Neurosci 1992;15:403-442.
205. Miller LE, Holdefer RN, Houk JC: The role of the cerebellum in modulating voluntary limb movement commands. Arch Ital Biol 2002;140:175-183.
206. Holdefer RN, Miller LE, Chen LL, Houk JC, et al: Functional connectivity between cerebellum and primary motor cortex in the awake monkey. J Neurophysiol 2000;84:585-590.
207. Iloeje SO: Cerebellar ataxia in childhood: A review of clinical features, investigative findings and aetiology in 30 cases. East Afr Med J 1992;69:58-63.
208. Barto AG, Fagg AH, Sitkoff N, Houk JC: A cerebellar model of timing and prediction in the control of reaching. Neural Comput 1999;11:565-594.
209. Ito M: Mechanisms of motor learning in the cerebellum. Brain Res 2000;886:237-245.
210. Thach WT: A role for the cerebellum in learning movement coordination. Neurobiol Learn Mem 1998;70:177-188.
211. Glickstein M: The cerebellum and motor learning. Curr Opin Neurobiol 1992;2:802-806.
212. Kawato M, Gomi H: The cerebellum and VOR/OKR learning models. Trends Neurosci 1992;15:445-453.
213. Ito M: Evidence for synaptic plasticity in the cerebellar cortex. Acta Morphol Hung 1983;31:213-218.
214. Ito M: Experimental verification of Marr-Albus' plasticity assumption for the cerebellum. Acta Biol 1982;33:189-199.
215. Marr D: A theory of cerebellar cortex. J Physiol 1969;202:437-470.
216. Bjegovic L: Acute cerebellar ataxia of childhood. Acta Univ Carol Med Monogr 1976;75:58-60.
217. Barth PG: Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev 1993;15:411-422.
218. Andersson PB, Rando TA: Neuromuscular disorders of childhood. Curr Opin Pediatr 1999;11:497-503.
219. Lentell G, Baas B, Lopez D, et al: The contributions of proprioceptive deficits, muscle function, and anatomic laxity to functional instability of the ankle. J Orthop Sports Phys Ther 1995;21:206-215.
220. Rozzi SL, Lephart SM, Gear WS, Fu FH: Knee joint laxity and neuromuscular characteristics of male and female soccer and basketball players. Am J Sports Med 1999; 27:312-319.
221. Factor SA, Podskalny GD, Molho ES: Psychogenic movement disorders: Frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry 1995;59: 406-412.
222. Marjama J, Troster AI, Koller WC: Psychogenic movement disorders. Neurol Clin 1995;13:283-297.
223. Graybiel AM: The basal ganglia and cognitive pattern generators. Schizophr Bull 1997;23:459-469.
224. Ghika J, Ghika-Schmid F, Bogousslasvky J: Parietal motor syndrome: A clinical description in 32 patients in the acute phase of pure parietal strokes studied prospectively. Clin Neurol Neurosurg 1998;100:271-282.
225. Rossi S, Pasqualetti P, Tecchio F, et al., Modulation of corticospinal output to human hand muscles following deprivation of sensory feedback. Neuroimage 1998;8:163-175.
226. Leonard CT, Kane J, Perdaems J, et al: Neural modulation of muscle contractile properties during fatigue: Afferent feedback dependence. Electroencephalogr Clin Neurophysiol 1994;93:209-217.
227. Campbell SK: Quantifying the effects of interventions for movement disorders resulting from cerebral palsy. J Child Neurol 1996;11(Suppl 1):S61-S70.